Security key
M40527109
Entera Bio Ltd. - Ordinary Shares, par value per share NIS 0.0000769 (ENTX)
CUSIP: M40527109
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Ordinary Shares, par value per share NIS 0.0000769
- Total 13F shares
- 414,726
- Total 13F value
- $735,380
- Share change
- +314,665
- SEC-reported price per share
- $1.77
- Number of holders
- 5
- Value change
- +$557,822
- Number of buys
- 3
- Number of sells
- 2
- Shares outstanding
- 170,503,000
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
5
Top holders
5
ENTX full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
Entera Bio Ltd. SEC filings
Entera Bio Ltd. company facts
Broader feeds
Reporting periods
Holder history for CUSIP M40527109
Recent filing periods:
Ownership snapshot
Top reported holders of ENTX - Entera Bio Ltd. - Ordinary Shares, par value per share NIS 0.0000769 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
OPKO HEALTH, INC.
Disclosed value leader
OPKO HEALTH, INC.
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G
13F
3/4/5
Lead comparable stake: 8.1%
13D/G row: OPKO HEALTH, INC.
Showing 1-6 of 15 holder rows.
Quick read
OPKO HEALTH, INC. leads the comparable SEC ownership view at 8.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens OPKO HEALTH, INC.'s linked filing trail.
Comparable ownership
Top 5
OPKO HEALTH, INC.
8.1%
Point72 Asset Management, L.P.
2.6%
Knoll Capital Management, LLC
3.4%
RENAISSANCE TECHNOLOGIES LLC
0.28%
Parkman Healthcare Partners LLC
0.17%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| OPKO HEALTH, INC. |
13D/G
|
8.1%
|
$8,660,281
3,685,226 shares
|
$0 | 16 Mar 2025 |
| Point72 Asset Management, L.P. |
13D/G
13F
Company
|
2.6%
|
$2,271,583
1,183,116 shares
|
-$2,915,412 | 30 Sep 2025 |
| Knoll Capital Management, LLC |
13F
3/4/5
Company · 10%+ Owner
|
3.4%
|
$6,470,066
5,881,879 shares
|
— | 31 Mar 2026 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.28%
|
$525,521
473,442 shares
|
— | 31 Mar 2026 |
| Parkman Healthcare Partners LLC |
13F
Company
|
0.17%
|
$320,424
288,670 shares
|
— | 31 Mar 2026 |
| CITADEL ADVISORS LLC |
13F
Company
|
0.14%
|
$272,590
245,577 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
5
Shares
414,726
Rows available
5
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
26
Q2 2026 holders
5
Holder diff
-21
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend